Targeting tumours with genetically enhanced T lymphocytes

被引：414

作者：

Sadelain, M

Rivière, I

Brentjens, R

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA

来源：

NATURE REVIEWS CANCER | 2003年 / 3卷 / 01期

关键词：

D O I：

10.1038/nrc971

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The genetic modification of T lymphocytes is an important approach to investigating normal T-cell biology and to increasing antitumour immunity. A number of genetic strategies aim to increase the recognition of tumour antigens, enhance antitumour activities and prevent T-cell malfunction. T cells can also be engineered to increase safety, as well as to express markers that can be tracked by non-invasive imaging technologies. Genetically modified T cells are therefore proving to be of great value for basic immunology and experimental immunotherapy.

引用

页码：35 / 45

页数：11

共 50 条

[31] Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours [J].

Iacovazzo, Donato ;

Chiloiro, Sabrina ;

Carlsen, Eivind ;

Bianchi, Antonio ;

Giampietro, Antonella ;

Tartaglione, Tommaso ;

Bima, Chiara ;

Bracaccia, Maria Elena ;

Lugli, Francesca ;

Lauretti, Liverana ;

Anile, Carmelo ;

Gessi, Marco ;

Colosimo, Cesare ;

Rindi, Guido ;

Pontecorvi, Alfredo ;

Korbonits, Marta ;

De Marinis, Laura .

ENDOCRINE, 2020, 67 (03) :651-658

[32] Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours [J].

Donato Iacovazzo ;

Sabrina Chiloiro ;

Eivind Carlsen ;

Antonio Bianchi ;

Antonella Giampietro ;

Tommaso Tartaglione ;

Chiara Bima ;

Maria Elena Bracaccia ;

Francesca Lugli ;

Liverana Lauretti ;

Carmelo Anile ;

Marco Gessi ;

Cesare Colosimo ;

Guido Rindi ;

Alfredo Pontecorvi ;

Márta Korbonits ;

Laura De Marinis .

Endocrine, 2020, 67 :651-658

[33] Targeting tumours [radiotherapy] [J].

Greenaway, Beth .

Engineering and Technology, 2008, 3 (17) :44-47

[34] Targeting tumours with HSV [J].

Fricker, J .

DRUG DISCOVERY TODAY, 2000, 5 (01) :5-6

[35] Genetically determined gonadal tumours in children [J].

Audí, L ;

Torán, N ;

Piró, C ;

Gussinyé, M ;

Carrascosa, A .

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 :1215-1225

[36] CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting [J].

Norell, Hakan ;

Zhang, Yi ;

McCracken, James ;

da Palma, Telma Martins ;

Lesher, Aaron ;

Liu, Yueying ;

Roszkowski, Jeffrey J. ;

Temple, Anquanette ;

Callender, Glenda G. ;

Clay, Timothy ;

Orentas, Rimas ;

Guevara-Patino, Jose ;

Nishimura, Michael I. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (06) :851-862

[37] CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting [J].

Håkan Norell ;

Yi Zhang ;

James McCracken ;

Telma Martins da Palma ;

Aaron Lesher ;

Yueying Liu ;

Jeffrey J. Roszkowski ;

Anquanette Temple ;

Glenda G. Callender ;

Timothy Clay ;

Rimas Orentas ;

José Guevara-Patiño ;

Michael I. Nishimura .

Cancer Immunology, Immunotherapy, 2010, 59 :851-862

[38] A Platform for the Scalable Derivation of Genetically-Enhanced T and NK Lymphocytes from Naive Human Induced Pluripotent Stem Cells for Cancer Immunotherapy [J].

Clarke, Raedun ;

Kim, William ;

Groff, Brian ;

Abujarour, Ramzey ;

Robinson, Megan ;

Huang, Xiaosong ;

Sahaf, Newsha ;

Raynel, Sarah ;

Rezner, Betsy ;

Robbins, David ;

Guerrettaz, Lisa ;

Shoemaker, Daniel ;

Valamehr, Bahram .

BLOOD, 2015, 126 (23)

[39] ENHANCED SUSCEPTIBILITY TO HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CD4(+) T-LYMPHOCYTES GENETICALLY DEFICIENT IN CD43 [J].

SRINIVAS, RV ;

SU, T ;

TRIMBLE, LA ;

LIEBERMAN, J ;

ARDMAN, B .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (09) :1015-1021

[40] Targeting the tumour vasculature with CAR T-cells for treatment of solid tumours [J].

Sanchez-Nieto, J. M. ;

Guijaro-Leach, J. J. ;

Camicia, R. ;

Keogh, A. ;

Ricardo, C. P. ;

Labbe, R. ;

Petrovic, R. ;

Gargiulo, L. ;

Robinson, J. ;

Zhuang, X. ;

Jinks, E. ;

Whitworth, K. ;

Bystrom, J. ;

Sharif, M. ;

Nagy, Z. ;

Tordo, J. ;

Mccoy, R. ;

Kallmeier, R. ;

Sharpe, M. ;

Bicknell, R. ;

Lee, S. ;

Munye, M. M. .

HUMAN GENE THERAPY, 2019, 30 (08) :A14-A15

← 1 2 3 4 5 →